Inflammation and its association with glucose disorders and cardiovascular disease.

Item

http://www.wikidata.org/entity/Q36116347

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

2003年论文

@zh

2003年论文

@zh-cn

name

Inflammation and its association with glucose disorders and cardiovascular disease.

@ast

Inflammation and its association with glucose disorders and cardiovascular disease.

@en

type

Item

label

Inflammation and its association with glucose disorders and cardiovascular disease.

@ast

Inflammation and its association with glucose disorders and cardiovascular disease.

@en

prefLabel

Inflammation and its association with glucose disorders and cardiovascular disease.

@ast

Inflammation and its association with glucose disorders and cardiovascular disease.

@en

P1476

Inflammation and its association with glucose disorders and cardiovascular disease.

@en

P2093

Eric Freedland

http://www.w3.org/2001/XMLSchema#string

Joshua Barzilay

http://www.w3.org/2001/XMLSchema#string

P2860

Serum vitamin C concentration is low in peripheral arterial disease and is associated with inflammation and severity of atherosclerosis

Modulation of C-reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs

Soluble cell adhesion molecules in hypertriglyceridemia and potential significance on monocyte adhesion

C-reactive protein-mediated low density lipoprotein uptake by macrophages: implications for atherosclerosis.

Pravastatin and the development of diabetes mellitus: evidence for a protective treatment effect in the West of Scotland Coronary Prevention Study.

Novel mechanism for endothelial dysfunction: dysregulation of dimethylarginine dimethylaminohydrolase.

C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue?

Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia.

Insulin-resistant lipolysis in abdominally obese hypertensive individuals. Role of the renin-angiotensin system.

Circulating levels of factor VII, fibrinogen, and von Willebrand factor and features of insulin resistance in first-degree relatives of patients with NIDDM.

P2888

00024677-200302020-00002

P304

85-94

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2165/00024677-200302020-00002

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2003-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1043884802

http://www.w3.org/2001/XMLSchema#string

P698

15871545

http://www.w3.org/2001/XMLSchema#string